News & Events

What’s going on at RA Capital

Name: RA Capital
Price range: $

For media inquiries please reach out.

media@racap.com

06/23/26

How RA Capital is offering its biotechs ‘Chinese clinical expertise in a box’

In The Media

Healthcare

09/30/25

RA Capital Management Funds Expansion of ARS Pharma Commercial Activity, Expands Portfolio of Financing Solutions for Innovative Healthcare Companies

RA Capital News

Healthcare

07/22/25

RA Capital Management Announces $120 Million Planetary Health Fund

RA Capital News

Planetary Health

05/27/25

New Study Reveals Agriculture as Largest, Most Resource-Intensive Industry on Earth

RA Capital News

Planetary Health

12/11/24

RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie

RA Capital News

Healthcare

09/18/24

RA Capital Launches Structured Capital Solutions

RA Capital News

10/28/20

Peter Kolchinsky on Pharma’s Soul

In The Media

Healthcare

09/10/20

America, the Engine of Biomedical Discovery, Should Be Trump’s ‘Most Favored Nation’

In The Media

Healthcare

06/03/20

IDEA Collider | Pharma Book Club | Peter Kolchinsky

In The Media

Healthcare

05/26/20

If Trikafta Isn’t Good Enough for ICER, What Drug Is?

In The Media

Healthcare

03/02/20

Covid-19 Teaches Us the Real Definition of a ‘Novel’ Drug

In The Media

Healthcare

12/22/19

PM Corner: A Conversation with RA Capital’s Peter Kolchinsky

In The Media

Healthcare

12/11/17

Q&A: Biotech Investing with Crossover Fund RA Capital

In The Media

Healthcare

08/03/15

RA Capital: Flexibility builds innovation

In The Media

Healthcare

01/26/15

Hepatitis C Commercial Game Theory

In The Media

Healthcare

12/22/14

Rethinking Venture Philanthropy After the Kalydeco Windfall

In The Media

Healthcare

07/08/13

How to Save $200 Billion and Cure Hepatitis C

In The Media

Healthcare

09/17/12

Solution Development: A Model For Structuring Biotechs And Developing Better Drugs

In The Media

Healthcare

08/02/11

How To Create A Lasting Peace Between Biotech Management, Shareholders And Employees

In The Media

Healthcare

Showing 1-21 of 21 posts in All Categories

Rapport

The hub for biotech and planetary health insight and opinion

Rapport is an online communications hub for members of the biotech and planetary health communities to share their ideas, problems, and solutions. Founded and run by employees of RA Capital, Rapport is a place to gather insight and opinions from across these industries.

What’s going on at RA Capital

How RA Capital is offering its biotechs ‘Chinese clinical expertise in a box’

RA Capital Management Funds Expansion of ARS Pharma Commercial Activity, Expands Portfolio of Financing Solutions for Innovative Healthcare Companies

RA Capital Management Announces $120 Million Planetary Health Fund

New Study Reveals Agriculture as Largest, Most Resource-Intensive Industry on Earth

RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie

RA Capital Launches Structured Capital Solutions

Peter Kolchinsky on Pharma’s Soul

America, the Engine of Biomedical Discovery, Should Be Trump’s ‘Most Favored Nation’

IDEA Collider | Pharma Book Club | Peter Kolchinsky

If Trikafta Isn’t Good Enough for ICER, What Drug Is?

Covid-19 Teaches Us the Real Definition of a ‘Novel’ Drug

PM Corner: A Conversation with RA Capital’s Peter Kolchinsky

The Biotech Social Contract

Investing Upstream

Q&A: Biotech Investing with Crossover Fund RA Capital

RA Capital: Flexibility builds innovation

Hepatitis C Commercial Game Theory

Rethinking Venture Philanthropy After the Kalydeco Windfall

How to Save $200 Billion and Cure Hepatitis C

Solution Development: A Model For Structuring Biotechs And Developing Better Drugs

How To Create A Lasting Peace Between Biotech Management, Shareholders And Employees

News & Events articles